Associated Press Fairfield looks to end streak vs Manhattan March 5, 2020 Share This StoryFacebookTwitteremailPrintLinkedinRedditFairfield (11-19, 7-12) vs. Manhattan (12-16, 8-11)Draddy Gymnasium, Riverdale, New York; Friday, 7 p.m. ESTBOTTOM LINE: Manhattan looks to extend Fairfield’s conference losing streak to five games. Fairfield’s last MAAC win came against the Niagara Purple Eagles 61-60 on Feb. 21. Manhattan lost 71-59 to Rider in its most recent game. BIG MEN ON CAMPUS: The Stags are led by juniors Jesus Cruz and Taj Benning. Cruz has averaged 10.9 points while Benning has recorded 9.9 points and 4.6 rebounds per game. The Jaspers have been led by Pauly Paulicap and Tykei Greene, who are averaging 10 and 10.4 points, respectively.JUMPING FOR JESUS: Cruz has connected on 22.2 percent of the 63 3-pointers he’s attempted and has made 2 of 8 over the last five games. He’s also made 69.4 percent of his foul shots this season.SLIPPING AT 64: Fairfield is 0-13 when it allows at least 64 points and 11-6 when it holds opponents to less than 64.LONG-RANGE THREAT: Fairfield’s Landon Taliaferro has attempted 184 3-pointers and connected on 33.7 percent of them, and is 7 for 23 over his last three games.DID YOU KNOW: The Fairfield defense has allowed only 63.4 points per game to opponents, which is the 28th-best mark in the country. The Manhattan offense has produced just 63 points through 28 games (ranked 296th among Division I teams).___ For more AP college basketball coverage: https://apnews.com/Collegebasketball and http://twitter.com/AP_Top25___This was generated by Automated Insights, http://www.automatedinsights.com/ap, using data from STATS LLC, https://www.stats.com
HAVANA, Cuba – Ask the authorities in China, South Korea, Germany, and Italy about the Cuban drug Interferon Alpha 2B—as their efforts at stemming the contagion of the novel coronavirus (COVID-19) are placed in the spotlight—and their response would reflect a more positive outcome.Out of a confirmed infection rate of 8,000 persons in South Korea, 72 succumbed to the virus. In Germany, just three persons died out of the 3,156 infected by this deadly virus, while the numbers in China, which was the epicenter of this pandemic, had approximately 3,500 deaths from a confirmed infection of close to 100,000 individuals.Currently, a team of Cuban doctors alongside their Chinese counterparts, armed with the Interferon Alpha 2B, are in Italy to help that beleaguered nation in an attempt to stem a death toll rate, which is considerably worse than what was experienced at the height of the COVID-19 crisis in Wuhan, China.Meanwhile, here in the United States, we’re scrambling to respond to COVID-19. We’re lagging behind in providing testing to citizens, many of whom researchers are saying may have already contracted the virus. In fact, scientists are saying the true numbers in the U.S. are way above the official Centers for Disease Control and Prevention (CDC) count of 10,442 cases and 150 deaths, up to press time.When compared with other countries such as South Korea and Germany, the number of confirmed coronavirus-linked deaths in the U.S. is staggering. As states ramp up testing, the number of cases is expected to climb exponentially and we’re simply unprepared to handle a large-scale pandemic. The U.S. currently has no vaccines available and no established treatments. We’re in a race against the clock, and while the Federal government touts two potential treatments—the malaria drug Chloroquine and the experimental antiviral drug Remdesevir—Cuba’s Interferon Alpha 2B is being used successfully around the globe.So what is this Interferon Alpha 2B, which is now being thrust on the world stage as one of the leading anti-COVID-19 drugs in response to the global pandemic? It is one of 22 drugs that has been developed in Cuba since 1986 by its Center for Genetic Engineering and Biotechnology (CIGB) and has been used as a treatment for HIV-AIDS, hepatitis B and C, herpes zoster or shingles, dengue and different types of cancers.Interferons are ‘signaling’ proteins, explains Dr. Helen Yaffe of Glasgow University, an expert on Cuba. These proteins are produced and released by the body in response to infections and alert nearby cells to heighten their antiviral defenses. It is not a cure or a vaccine to COVID-19 but rather an antiviral that boosts the human defense system.There are currently manufacturing relationships between the Caribbean island and China for this stellar product and it is highly recommended by medical specialists for its ability to fight the COVID-19 virus. During the onset of the virus in Wuhan province, the Chinese authorities found it to be exceptional in destroying the virus from thousands of its citizens who had contracted this respiratory disease at the earliest stages.Since the success of this antiviral drug has become public knowledge, Cuba has been flooded with requests from all across the globe, including, Africa, Europe, Latin and South America and Caribbean nations that make up the Organization of Eastern Caribbean States.
Puig spent the first six years of his MLB career with the Dodgers before he was sent to the Reds in a December trade.Reds manager David Bell praised Puig’s performance with the team so far. MLB trade rumors: Rays have ‘checked in’ on Nicholas Castellanos, spoken with Giants about relievers MLB trade rumors: Tigers’ asking price for Matthew Boyd could prevent deal MLB trade rumors: ‘Chances are pretty high’ Mets move Zack Wheeler before deadline “It’s been impressive,” Bell said. “It doesn’t really feel like it’s going away. I think he really made some good adjustments. He’s on time with the fastball and it’s allowing him more time to recognize the off-speed pitches. He’s hitting the ball hard, really hard, consistently. He’s been hot, but I think he worked hard to get to the point he’s gotten and hopefully, he can keep that going.”President of baseball operations Dick Williams said at the All-Star break the Reds were planning to be buyers this month, but they’re just 3-5 in their last eight games, which could change that thinking, according to The Athletic.The Reds entered Wednesday 6 1/2 games out of the second National League wild-card spot with a 46-53 record. Puig is slashing .262/.311/.496 with 22 home runs and 59 RBIs in 94 games with Cincinnati this season. He has also scored 49 runs and stolen 13 bases.“When I’m going into each AB, (I’m) looking for something I can hit, something in the zone that I can make contact (with),” Puig said about his success this season, via Cincinnati.com. “In the first couple of weeks, I go into there to try to get hits and swing at every ball. Now, I slowed down myself, try to put the ball in play and that’s helped me out a lot.” Related News Yasiel Puig may be with a new team soon.The 28-year-old outfielder is “a particularly strong candidate to be moved” by the Reds before the July 31 trade deadline, according to a report from The Athletic, which cited unidentified league sources.